Abiopharma

🔍 Brottem John L. (Executive)

Company: Outset Medical, Inc. (OM)

Report Date: 2026-01-07

Detailed Transactions and Holdings:

• Sold 224 shares of Common Stock at $4.27 per share (Direct)
  Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 46,271.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 447 shares of Common Stock underlying PSUs (i) which were, as previously reported, originally earned based on the achievement of applicable performance criteria as of December 31, 2024 or January 6, 2025, as applicable, as certified by the Compensation Committee of the Issuer's Board of Directors on January 17, 2025 and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.